Have a look at this editorial published on @EUplatinum. This is an interesting summary of the #biomarkers that impact clinical practice for patients with #urothelial cancer. Today @Luca_Afferi et al. in #PuigvertInScience on behalf of the @EAU_YAUrothel Read the article 👇 🔗pubmed.ncbi.nlm.nih.gov/3926…

"#ECIRS is a feasible, safe & efficient procedure in #children with complex renal #lithiasis, decreasing the number of procedures needed for stone free." Dr. #YesicaQuiroz in #PuigvertinScience Read open access article here👇🏽 🔗pubmed.ncbi.nlm.nih.gov/3913…

Interesting reading: Social media is shaping the future of #urology! 🌐 With over 5 billion active users worldwide, it’s a tool we use for patient #education, support, and peer connections. But be aware of #misinformation and #privacyrisks. Dr. @emiliani_e in #PuigvertinScience 🔗pubmed.ncbi.nlm.nih.gov/3921… #Urology #SoMe

New insights regarding autosomal dominant #Alport syndrome 👇 "Individuals with COL4A3/COL4A4 genes pathogenic variants are prone to develop #kidneycysts more frequently than the general population, and their presence is related to age and to eGFR" @m_furlano in #PuigvertinScience 🔗Read #OpenAccess article pubmed.ncbi.nlm.nih.gov/3831… 🫴Our special thanks to our excellent genetic kidney diseases team from #NefroPuigvert: @m_furlano @melipilco @marcpybus @ervierar @lfayosarizon @JHernandez_RX @bet_ars @torra_roser @grberna. As well as to all coauthors @JoseLAlberoD95 @EleGomGar @HugoVergPerez @JaimeMazonRuiz @IRSantPau @CIBER_ESP 🙌

"Solid organ #transplant recipients are thought to have more complications when implanting a #PenileProsthesis. Is this concern real or unfounded? Could we offer this procedure to them?" Dr. @AngeloTerrito in #PuigvertinScience 👇 🔗pubmed.ncbi.nlm.nih.gov/3902… @YAU_Transplant @yoursexmedjour

"Excited to share significant advancements in managing infected liver cysts in #PLD #ADPKD! Our multidisciplinary team at Fundació #Puigvert & @HospitalSantPau is dedicated to delivering the best care for #ADPKD patients @EuRefNetwork" Dr. @torra_roser, President of @ERAkidney in #PuigvertinScience 👉pubmed.ncbi.nlm.nih.gov/3887…

Ferran Algaba Arrea, today in #PuigvertinScience, about Urologic #Pathology👇 “The journey of determining PD-L1 expression in muscle-invasive urothelial carcinoma: Within the complex mechanism of antigen presentation to immune cells in order to destroy #neoplastic cells, the latter are protected by PD-L1 molecules and are therefore targets for #immunotherapy. Hence the determination of PD-L1 expression in tumor cells & immune cells is considered a marker for predicting treatment response. 👉In order to respond to all possible situations that may arise, now and in the future, the Spanish Society of #AnatomicPathology @SEAP_IAP gathered a group of pathologists, together with a uro-oncologist, to draw up a #guide of recommendations based on currently available evidence. The questions I have tried to answer are: 🔘Which patients should be evaluated? 🔘Which sample is best for PD-L1 determination? 🔘Which antibody is best for invasive urothelial carcinoma? 🔘What to do if a first determination is negative? 🔘How should results be reported?” 🔗READ the article: pubmed.ncbi.nlm.nih.gov/3875… **Dr. Algaba is a well-known expert and national coordinator of Urologic Pathology at @SEAP_IAP, Chief of Anatomic Pathology Lab of Fundació #Puigvert

"#KidneyStones are becoming increasingly common. #Dent´s disease is one of the monogenic causes predisposing to stone formation. Early diagnosis & strict follow-up of these patients is important to avoid unnecessary treatment and prevent #CKD progression", @ldieguezag in #PuigvertinScience Check out this #OpenAccess article 👇 pubmed.ncbi.nlm.nih.gov/3892… Our thanks to all the authors @ldieguezag @melipilco @Koey_Kana @JBalana_ @emiliani_e @endouro @oangerri

"#RIRS has increased its indications in the #pediatric population over the years. However,when there is a high #stone burden,its SFR decreases and complications may increase. Cases should be properly selected for this #endourological technique." Dr. #YesicaQuiroz in #PuigvertinScience Read👇 🔗pubmed.ncbi.nlm.nih.gov/3887… Thanks to @OTRAXER, @D_Castellani, @drragoori, @Shresthanyl, @BujonsTur, @DrVCMohan, @RIRS_inDelhiNCR, @Casekerci, @ytanidir & all the authors of this work

"Characterising a reference approach to #TURBT from an international panel of experts. Towards a standardised education of young #urologists: #proficiency-based progression training curriculum for TURBT" @pietrosdiana in #PuigvertinScience 🔗pubmed.ncbi.nlm.nih.gov/3883… Special thanks to the authors 🙌 @pietrosdiana @agallioli @joanfundi @AlbertoBreda1 @Marco_Paciotti_ @NBuffi

"Introducing the Sysmex PA-100 System: a groundbreaking point-of-care solution for rapid #bacteriuria and antimicrobial susceptibility testing in just 45 minutes!🎉" Dr. Carla Benjumea @carla97_15 in #PuigvertinScience With: @alonso_tarres @kamaku33 🔗pubmed.ncbi.nlm.nih.gov/3882…

"#Ureteroscopy for #UTUC is a safe procedure with a low complication burden. However, patients who experience #intraoperative adverse events are at higher risk of developing #postoperative morbidity" @BasileG_ in #PuigvertInScience 👇 🔗pubmed.ncbi.nlm.nih.gov/3873… Thank you, authors @gallioli @AngeloTerrito @paoloverri05 @DrJM_Gaya @Luca_Afferi @pietrosdiana @ISanzgomez @ldieguezag @Aleuleri @camilleberquin @UROGavrilov @joanfundi @AlbertoBreda1

"#Prostate #MRI quality is essential for clinical decision making (e.g. #prostatebiopsy). The new PIQUAL v2 score provides better guidance on MRI #quality assessment and its clinical utility/application",  @F_Sanguedolce in #PuigvertinScience 👇🏽 🔗pubmed.ncbi.nlm.nih.gov/3878…

"Mini-ECIRS is a versatile and safe technique, even in #infants, allowing us in a single surgical time #stone free rates that would have required 2 or 3 surgeries", Dr. #YesicaQuiroz in #PuigvertInScience 🔗pubmed.ncbi.nlm.nih.gov/3851… #PediatricUrology #UroPuigvert

Simulation&proficiency-based progression #training programs: new #quality standard to gain surgical proficiency in #Urology. A shared pathway across disciplines to assess the impact of this novel training methodology on patient outcomes is needed. @BasileG_ in #PuigvertInScience

"Check out our paper about robotic retrograde intrarenal surgery using ILY system 🕹️🤖: our experience in @FPuigvert. Its future seems promising!" @FarreAlf in #PuigvertInScience 🔗pubmed.ncbi.nlm.nih.gov/3865… #RoboticSurgery

New frontiers with #robotic orthotopic #kidneytransplantion to expand the indications of #RAKT 🗣️ Today Dr. @AlbertoBreda1 in #PuigvertInScience Read the article 👇 bit.ly/3w1uHy4

"Pediatric #endourology requires miniaturization of all its instruments and the 7.5 Fr single use scope is a versatile & efficient tool in the pediatric #Stonedisease treatment", #YésicaQuiroz in #PuigvertInScience 🔗pubmed.ncbi.nlm.nih.gov/3855… @BujonsTur @Erikallorens @endouro

“#KidneyDisease has high global prevalence and is a #globalhealth concern; however, more than 10% of the world population suffer it silently" @torra_roser #NefroPuigvert, President elect @ERAkidney in #PuigvertInScience #CKD 🔗pubmed.ncbi.nlm.nih.gov/3857… @NDTsocial @OxfordJournals

"@FPuigvert as pionner in #RAKT participated in this multicenter European study. There is a trend in the adoption of the robotic technique in the #livingdonor #transplantation,increasing from 18 to 44 %." #PuigvertInScience @joanfundi 🔗pubmed.ncbi.nlm.nih.gov/3842…